- Published on
Toxicology – Jellyfish Envenomation
Source
Jellyfish are marine invertebrates belonging to the phylum Cnidaria, with thousands of species found worldwide. They are characterized by a bell-shaped body, trailing tentacles, and specialized stinging cells called nematocysts. Jellyfish are commonly encountered in coastal waters, particularly during warmer months, and often travel in groups.
Typical Presentation
Individuals typically present after sudden contact with tentacles while swimming, followed by immediate sharp pain and visible linear skin markings at the site of contact.
Clinical Features
Common Jellyfish
Stings usually cause painful, raised skin lesions resembling hives, sometimes with blistering, bleeding, or tissue damage. Associated symptoms may include swelling, weakness, headache, nausea, and vomiting.
Box Jellyfish
These are among the most dangerous species. Envenomation can cause severe pain, dark linear skin markings, muscle spasms, and systemic symptoms such as fever, nausea, and cardiovascular instability. In severe cases, rapid progression to cardiac or respiratory failure may occur.
Portuguese Man-of-War
Although not a true jellyfish, it causes similar but often more severe reactions, with a higher risk of systemic complications
.
Irukandji Syndrome
Following envenomation by certain small jellyfish, symptoms may initially be mild but progress within minutes to severe back pain, muscle cramps, abdominal pain, sweating, headache, hypertension, and tachycardia.
Mechanism of Action
Jellyfish deliver venom through nematocysts located on their tentacles. Upon contact, these structures discharge microscopic barbs that penetrate the skin and inject venom, causing immediate pain and inflammation.
Management
Initial treatment involves removing the person from the water and rinsing the affected area with seawater to prevent further nematocyst discharge. Vinegar may be applied in some cases to deactivate stinging cells before carefully removing any remaining tentacles. Most cases are self-limited, but severe envenomations—particularly from box jellyfish—may require antivenom and advanced supportive care.
Key Points
Source
Jellyfish are marine invertebrates belonging to the phylum Cnidaria, with thousands of species found worldwide. They are characterized by a bell-shaped body, trailing tentacles, and specialized stinging cells called nematocysts. Jellyfish are commonly encountered in coastal waters, particularly during warmer months, and often travel in groups.
Typical Presentation
Individuals typically present after sudden contact with tentacles while swimming, followed by immediate sharp pain and visible linear skin markings at the site of contact.
Clinical Features
Common Jellyfish
Stings usually cause painful, raised skin lesions resembling hives, sometimes with blistering, bleeding, or tissue damage. Associated symptoms may include swelling, weakness, headache, nausea, and vomiting.
Box Jellyfish
These are among the most dangerous species. Envenomation can cause severe pain, dark linear skin markings, muscle spasms, and systemic symptoms such as fever, nausea, and cardiovascular instability. In severe cases, rapid progression to cardiac or respiratory failure may occur.
Portuguese Man-of-War
Although not a true jellyfish, it causes similar but often more severe reactions, with a higher risk of systemic complications
.
Irukandji Syndrome
Following envenomation by certain small jellyfish, symptoms may initially be mild but progress within minutes to severe back pain, muscle cramps, abdominal pain, sweating, headache, hypertension, and tachycardia.
Mechanism of Action
Jellyfish deliver venom through nematocysts located on their tentacles. Upon contact, these structures discharge microscopic barbs that penetrate the skin and inject venom, causing immediate pain and inflammation.
Management
Initial treatment involves removing the person from the water and rinsing the affected area with seawater to prevent further nematocyst discharge. Vinegar may be applied in some cases to deactivate stinging cells before carefully removing any remaining tentacles. Most cases are self-limited, but severe envenomations—particularly from box jellyfish—may require antivenom and advanced supportive care.
Key Points
- Detached tentacles can still sting and should be handled carefully.
- Most jellyfish stings are mild and resolve without complications.
- Vinegar may worsen stings from certain species, so use should be species-appropriate.
- Even dead jellyfish can still cause envenomation.
- Published on
Toxicology – Black Widow Spider (Latrodectus) Envenomation
Source
Black widow spiders are found throughout the United States, especially in warmer southern regions. Only female spiders bite humans. They are typically identified by markings on the abdomen—most commonly a red hourglass on the underside. These spiders tend to inhabit dark, undisturbed areas such as woodpiles, garages, and sheds.
Typical Presentation
Patients often present after a painful spider bite followed by progressive muscle pain and systemic symptoms. In children, symptoms may be severe and mimic other acute conditions such as abdominal emergencies.
Clinical Features
The bite initially causes localized pain, followed by redness and sweating at the site. Systemic symptoms may include muscle cramps and fasciculations, severe abdominal pain and rigidity, nausea, vomiting, weakness, headache, dizziness, chest pain, and elevated blood pressure. In some cases, unusual findings such as priapism may occur. Symptoms tend to be more severe in children and older adults.
Mechanism of Action
The venom contains alpha-latrotoxin, a potent neurotoxin that triggers massive release of neurotransmitters by opening presynaptic calcium channels. This results in widespread neuromuscular and autonomic stimulation.
Management
Treatment is primarily supportive, focusing on pain control and symptom management. Muscle relaxants may be used for cramping. Intravenous calcium has been used in some cases, though benefits are variable. Antivenom may be considered in severe cases, particularly in high-risk patients or those with significant systemic symptoms.
Key Points
Source
Black widow spiders are found throughout the United States, especially in warmer southern regions. Only female spiders bite humans. They are typically identified by markings on the abdomen—most commonly a red hourglass on the underside. These spiders tend to inhabit dark, undisturbed areas such as woodpiles, garages, and sheds.
Typical Presentation
Patients often present after a painful spider bite followed by progressive muscle pain and systemic symptoms. In children, symptoms may be severe and mimic other acute conditions such as abdominal emergencies.
Clinical Features
The bite initially causes localized pain, followed by redness and sweating at the site. Systemic symptoms may include muscle cramps and fasciculations, severe abdominal pain and rigidity, nausea, vomiting, weakness, headache, dizziness, chest pain, and elevated blood pressure. In some cases, unusual findings such as priapism may occur. Symptoms tend to be more severe in children and older adults.
Mechanism of Action
The venom contains alpha-latrotoxin, a potent neurotoxin that triggers massive release of neurotransmitters by opening presynaptic calcium channels. This results in widespread neuromuscular and autonomic stimulation.
Management
Treatment is primarily supportive, focusing on pain control and symptom management. Muscle relaxants may be used for cramping. Intravenous calcium has been used in some cases, though benefits are variable. Antivenom may be considered in severe cases, particularly in high-risk patients or those with significant systemic symptoms.
Key Points
- Symptoms may mimic conditions such as acute abdomen or cardiac ischemia.
- Severe complications can include hypertensive crises and respiratory compromise.
- Early recognition and supportive care are essential for good outcomes.
- Published on
Toxicology – Black Widow Spider (Latrodectus) Envenomation
Source
Black widow spiders are found throughout the United States, especially in warmer southern regions. Only female spiders bite humans. They are typically identified by markings on the abdomen—most commonly a red hourglass on the underside. These spiders tend to inhabit dark, undisturbed areas such as woodpiles, garages, and sheds.
Typical Presentation
Patients often present after a painful spider bite followed by progressive muscle pain and systemic symptoms. In children, symptoms may be severe and mimic other acute conditions such as abdominal emergencies.
Clinical Features
The bite initially causes localized pain, followed by redness and sweating at the site. Systemic symptoms may include muscle cramps and fasciculations, severe abdominal pain and rigidity, nausea, vomiting, weakness, headache, dizziness, chest pain, and elevated blood pressure. In some cases, unusual findings such as priapism may occur. Symptoms tend to be more severe in children and older adults.
Mechanism of Action
The venom contains alpha-latrotoxin, a potent neurotoxin that triggers massive release of neurotransmitters by opening presynaptic calcium channels. This results in widespread neuromuscular and autonomic stimulation.
Management
Treatment is primarily supportive, focusing on pain control and symptom management. Muscle relaxants may be used for cramping. Intravenous calcium has been used in some cases, though benefits are variable. Antivenom may be considered in severe cases, particularly in high-risk patients or those with significant systemic symptoms.
Key Points
Source
Black widow spiders are found throughout the United States, especially in warmer southern regions. Only female spiders bite humans. They are typically identified by markings on the abdomen—most commonly a red hourglass on the underside. These spiders tend to inhabit dark, undisturbed areas such as woodpiles, garages, and sheds.
Typical Presentation
Patients often present after a painful spider bite followed by progressive muscle pain and systemic symptoms. In children, symptoms may be severe and mimic other acute conditions such as abdominal emergencies.
Clinical Features
The bite initially causes localized pain, followed by redness and sweating at the site. Systemic symptoms may include muscle cramps and fasciculations, severe abdominal pain and rigidity, nausea, vomiting, weakness, headache, dizziness, chest pain, and elevated blood pressure. In some cases, unusual findings such as priapism may occur. Symptoms tend to be more severe in children and older adults.
Mechanism of Action
The venom contains alpha-latrotoxin, a potent neurotoxin that triggers massive release of neurotransmitters by opening presynaptic calcium channels. This results in widespread neuromuscular and autonomic stimulation.
Management
Treatment is primarily supportive, focusing on pain control and symptom management. Muscle relaxants may be used for cramping. Intravenous calcium has been used in some cases, though benefits are variable. Antivenom may be considered in severe cases, particularly in high-risk patients or those with significant systemic symptoms.
Key Points
- Symptoms may mimic conditions such as acute abdomen or cardiac ischemia.
- Severe complications can include hypertensive crises and respiratory compromise.
- Early recognition and supportive care are essential for good outcomes.
- Published on
Toxicology – Scorpion Envenomation
Source
Venomous scorpions are found in various regions worldwide. In North America, the bark scorpion is the most clinically significant species, commonly found in the southwestern United States and Mexico. Other dangerous species exist in parts of Africa, India, and the Middle East.
Typical Presentation
Patients typically present after a sudden, painful sting. In more severe cases, symptoms may rapidly progress to systemic toxicity, especially in vulnerable individuals such as children or the elderly.
Clinical Features
Most stings in North America cause localized pain, redness, and swelling. More severe envenomations may produce systemic symptoms including tachycardia, abnormal heart rhythms, elevated blood pressure, hyperthermia, excessive sweating, drooling, dilated pupils, abnormal eye movements (nystagmus), muscle twitching, clonus, and respiratory distress. Severe cases may also be associated with complications such as pancreatitis or coagulopathy.
Mechanism of Action
Scorpion venom contains a combination of neurotoxic and cytotoxic components. It affects ion channels, particularly by activating sodium channels and inhibiting potassium channels, leading to prolonged nerve and muscle excitation and autonomic instability.
Management
Treatment is primarily supportive. Pain is managed with analgesics, often including opioids. Benzodiazepines are used for muscle spasms and agitation. In cases of significant systemic toxicity, antivenom (such as Centruroides-specific antivenom) may be administered when available.
Key Points
Source
Venomous scorpions are found in various regions worldwide. In North America, the bark scorpion is the most clinically significant species, commonly found in the southwestern United States and Mexico. Other dangerous species exist in parts of Africa, India, and the Middle East.
Typical Presentation
Patients typically present after a sudden, painful sting. In more severe cases, symptoms may rapidly progress to systemic toxicity, especially in vulnerable individuals such as children or the elderly.
Clinical Features
Most stings in North America cause localized pain, redness, and swelling. More severe envenomations may produce systemic symptoms including tachycardia, abnormal heart rhythms, elevated blood pressure, hyperthermia, excessive sweating, drooling, dilated pupils, abnormal eye movements (nystagmus), muscle twitching, clonus, and respiratory distress. Severe cases may also be associated with complications such as pancreatitis or coagulopathy.
Mechanism of Action
Scorpion venom contains a combination of neurotoxic and cytotoxic components. It affects ion channels, particularly by activating sodium channels and inhibiting potassium channels, leading to prolonged nerve and muscle excitation and autonomic instability.
Management
Treatment is primarily supportive. Pain is managed with analgesics, often including opioids. Benzodiazepines are used for muscle spasms and agitation. In cases of significant systemic toxicity, antivenom (such as Centruroides-specific antivenom) may be administered when available.
Key Points
- Scorpions fluoresce under ultraviolet (Wood’s lamp) light, aiding identification.
- Severe toxicity is more likely in children and older adults.
- Antivenom should be considered in patients with systemic symptoms.
- Published on
Toxicology – Elapid Snake Envenomation
Source
Elapid snakes are found primarily in tropical and subtropical regions worldwide. They possess fixed, hollow fangs used to deliver venom. This group includes coral snakes, cobras, mambas, taipans, adders, and certain sea snakes.
Typical Presentation
A patient may present after a bite from a brightly colored or unfamiliar snake, initially with mild local symptoms but progressing to neurological changes. Early complaints may include tingling or numbness at the bite site.
Clinical Features
Local findings are often less severe than with pit viper bites and may include mild pain, paresthesia, and minimal swelling. Systemic effects are more prominent and include nausea, vomiting, altered mental status, difficulty swallowing, double vision, drooping eyelids (ptosis), muscle twitching, excessive salivation, jaw stiffness, hypotension, tachycardia, and potentially respiratory failure due to paralysis.
Mechanism of Action
Elapid venom is primarily neurotoxic. It interferes with neuromuscular transmission by blocking postsynaptic acetylcholine receptors, particularly at nicotinic receptors in skeletal muscle. This can lead to progressive paralysis, including involvement of the diaphragm and respiratory muscles.
Management
Treatment is mainly supportive, with close monitoring of airway and respiratory function. Early intubation and mechanical ventilation should be considered if there are signs of respiratory compromise. Consultation with poison control or toxicology specialists is essential to determine availability of appropriate antivenom (such as coral snake antivenin, where applicable).
Key Points
- Elapid bites often cause minimal local injury but significant systemic neurotoxicity.
- Respiratory failure is the most serious complication and requires prompt recognition.
- Some species require prolonged contact (e.g., coral snakes) to effectively deliver venom.
- Identification rules based on color patterns apply only in specific geographic regions and should be used cautiously.
- Published on
Toxicology – Crotalid Snake Envenomation
Source
Crotalid snakes (pit vipers) are the most common cause of venomous snakebites in the United States. These include rattlesnakes, copperheads, and cottonmouths (water moccasins). They are characterized by heat-sensing pits located near their eyes.
Typical Presentation
A patient presents after a snakebite, often involving provocation of the animal. Two puncture wounds (“fang marks”) are typically visible, followed by rapid onset of pain and swelling at the affected site.
Clinical Features
Initial symptoms include severe burning pain at the bite site, followed by redness, warmth, swelling, bruising, and blister formation. Edema may spread along the affected limb and can lead to compartment syndrome. Systemic manifestations may include nausea, vomiting, altered taste, tingling sensations, hypotension, coagulopathy (including disseminated intravascular coagulation), and cardiovascular collapse in severe cases.
Severity Classification
Mechanism of Action
Crotalid venom contains a mixture of cytotoxic, hemotoxic, and neurotoxic components that damage tissue, disrupt coagulation pathways, and may affect neuromuscular function.
Management
Initial evaluation includes laboratory studies such as complete blood count, coagulation profile (PT/PTT), fibrin levels, D-dimer, and creatine phosphokinase (CPK). Serial assessment of limb swelling is essential. Some bites may be “dry” (no venom injected) and require only supportive care.
For progressive local swelling or systemic toxicity, antivenom (CroFab) is indicated, typically starting with 4–6 vials. Patients require close monitoring, as repeat dosing may be necessary depending on clinical response.
Key Points
Source
Crotalid snakes (pit vipers) are the most common cause of venomous snakebites in the United States. These include rattlesnakes, copperheads, and cottonmouths (water moccasins). They are characterized by heat-sensing pits located near their eyes.
Typical Presentation
A patient presents after a snakebite, often involving provocation of the animal. Two puncture wounds (“fang marks”) are typically visible, followed by rapid onset of pain and swelling at the affected site.
Clinical Features
Initial symptoms include severe burning pain at the bite site, followed by redness, warmth, swelling, bruising, and blister formation. Edema may spread along the affected limb and can lead to compartment syndrome. Systemic manifestations may include nausea, vomiting, altered taste, tingling sensations, hypotension, coagulopathy (including disseminated intravascular coagulation), and cardiovascular collapse in severe cases.
Severity Classification
- Mild envenomation: Local pain and swelling without coagulation abnormalities
- Moderate envenomation: Local effects with evidence of coagulation disturbances
- Severe envenomation: Systemic toxicity such as shock, pulmonary edema, coagulopathy, and cardiovascular instability
Mechanism of Action
Crotalid venom contains a mixture of cytotoxic, hemotoxic, and neurotoxic components that damage tissue, disrupt coagulation pathways, and may affect neuromuscular function.
Management
Initial evaluation includes laboratory studies such as complete blood count, coagulation profile (PT/PTT), fibrin levels, D-dimer, and creatine phosphokinase (CPK). Serial assessment of limb swelling is essential. Some bites may be “dry” (no venom injected) and require only supportive care.
For progressive local swelling or systemic toxicity, antivenom (CroFab) is indicated, typically starting with 4–6 vials. Patients require close monitoring, as repeat dosing may be necessary depending on clinical response.
Key Points
- Not all snakebites result in envenomation; some are dry bites.
- Antivenom is the mainstay of treatment for significant envenomation.
- Surgical intervention such as fasciotomy is rarely required.
- Envenomation can evolve over time, so close observation is essential.
- Published on
Toxicology – Drug “Stuffers” and “Packers”
Overview
“Stuffers” and “packers” refer to individuals who conceal illicit drugs within their bodies, typically to evade law enforcement. These two groups differ significantly in the quantity of drugs involved, the method of concealment, and the associated risks.
Stuffers
Definition
Stuffers are individuals who rapidly swallow small amounts of drugs—commonly cocaine, crack, or heroin—when attempting to avoid detection. The packaging is often poorly secured, increasing the risk of leakage and absorption.
Detection
Diagnosis may rely on witness reports, patient disclosure, or clinical suspicion. Imaging studies such as plain abdominal X-rays may be used but are often unreliable in detecting small or poorly wrapped packets.
Toxicity
Symptoms can occur unpredictably depending on the substance and whether a packet ruptures. Sympathomimetic features (e.g., tachycardia, hypertension, agitation) are common with stimulant drugs, while other substances produce their respective toxidromes.
Management
Treatment often includes activated charcoal, particularly for substances like cocaine that bind well to it. Whole bowel irrigation (WBI) with polyethylene glycol solution may be considered depending on the situation.
Packers (“Body Packers”)
Definition
Packers, often referred to as “drug mules,” intentionally ingest large quantities of drugs—typically well-packaged—for transport across borders. The total amount can be substantial, often reaching hundreds of grams or more.
Detection
Imaging is more reliable in these cases. Plain abdominal X-rays may reveal multiple uniform radiopaque packets. If inconclusive, computed tomography (CT) with contrast is more sensitive.
Toxicity
If a packet ruptures, massive drug release can occur, often resulting in severe toxicity and a high risk of death, particularly with stimulants like cocaine.
Management
Patients with signs of obstruction or suspected packet rupture require urgent surgical evaluation. In stable, asymptomatic individuals, whole bowel irrigation is commonly used to facilitate passage of packets. Adjunctive medications such as antiemetics or prokinetics may be used. Activated charcoal may be considered selectively.
Key Points
Overview
“Stuffers” and “packers” refer to individuals who conceal illicit drugs within their bodies, typically to evade law enforcement. These two groups differ significantly in the quantity of drugs involved, the method of concealment, and the associated risks.
Stuffers
Definition
Stuffers are individuals who rapidly swallow small amounts of drugs—commonly cocaine, crack, or heroin—when attempting to avoid detection. The packaging is often poorly secured, increasing the risk of leakage and absorption.
Detection
Diagnosis may rely on witness reports, patient disclosure, or clinical suspicion. Imaging studies such as plain abdominal X-rays may be used but are often unreliable in detecting small or poorly wrapped packets.
Toxicity
Symptoms can occur unpredictably depending on the substance and whether a packet ruptures. Sympathomimetic features (e.g., tachycardia, hypertension, agitation) are common with stimulant drugs, while other substances produce their respective toxidromes.
Management
Treatment often includes activated charcoal, particularly for substances like cocaine that bind well to it. Whole bowel irrigation (WBI) with polyethylene glycol solution may be considered depending on the situation.
Packers (“Body Packers”)
Definition
Packers, often referred to as “drug mules,” intentionally ingest large quantities of drugs—typically well-packaged—for transport across borders. The total amount can be substantial, often reaching hundreds of grams or more.
Detection
Imaging is more reliable in these cases. Plain abdominal X-rays may reveal multiple uniform radiopaque packets. If inconclusive, computed tomography (CT) with contrast is more sensitive.
Toxicity
If a packet ruptures, massive drug release can occur, often resulting in severe toxicity and a high risk of death, particularly with stimulants like cocaine.
Management
Patients with signs of obstruction or suspected packet rupture require urgent surgical evaluation. In stable, asymptomatic individuals, whole bowel irrigation is commonly used to facilitate passage of packets. Adjunctive medications such as antiemetics or prokinetics may be used. Activated charcoal may be considered selectively.
Key Points
- Stuffers involve smaller amounts with higher risk of leakage due to poor packaging.
- Packers carry larger quantities with potentially fatal consequences if rupture occurs.
- Imaging plays a crucial role in diagnosis, especially in packers.
- Management ranges from supportive care to urgent surgical intervention depending on clinical status.
- Published on
Toxicology – Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
Source
MDMA is a synthetic recreational drug commonly sold as colorful tablets or capsules, often branded with logos. Due to its illicit production, purity is highly variable, and tablets are frequently mixed with other substances such as amphetamines, dextromethorphan, synthetic cathinones, or opioids. It is also known as ecstasy, E, X, or XTC.
Typical Presentation
Users often present after recreational use in party or club settings, describing heightened sensory experiences and emotional changes. Physical findings may include increased heart rate, elevated blood pressure, and mild sweating.
Clinical Features
Effects typically begin within 30–45 minutes and last several hours. Stimulant effects include tachycardia, hypertension, increased energy, rapid breathing, and dilated pupils. Psychologically, users may experience enhanced empathy, emotional openness, and altered perception. Adverse effects include agitation, hyperthermia, hyponatremia, and risk of serotonin syndrome. After the drug wears off, users often report fatigue and low mood. Chronic use has been associated with depressive symptoms.
Mechanism of Action
MDMA increases the release of serotonin, norepinephrine, and dopamine from presynaptic neurons, leading to both stimulant and empathogenic effects.
Management
Treatment is supportive. Benzodiazepines are used to control agitation, anxiety, and autonomic symptoms such as tachycardia. Careful monitoring for complications such as hyperthermia and electrolyte disturbances is important.
Key Points
Source
MDMA is a synthetic recreational drug commonly sold as colorful tablets or capsules, often branded with logos. Due to its illicit production, purity is highly variable, and tablets are frequently mixed with other substances such as amphetamines, dextromethorphan, synthetic cathinones, or opioids. It is also known as ecstasy, E, X, or XTC.
Typical Presentation
Users often present after recreational use in party or club settings, describing heightened sensory experiences and emotional changes. Physical findings may include increased heart rate, elevated blood pressure, and mild sweating.
Clinical Features
Effects typically begin within 30–45 minutes and last several hours. Stimulant effects include tachycardia, hypertension, increased energy, rapid breathing, and dilated pupils. Psychologically, users may experience enhanced empathy, emotional openness, and altered perception. Adverse effects include agitation, hyperthermia, hyponatremia, and risk of serotonin syndrome. After the drug wears off, users often report fatigue and low mood. Chronic use has been associated with depressive symptoms.
Mechanism of Action
MDMA increases the release of serotonin, norepinephrine, and dopamine from presynaptic neurons, leading to both stimulant and empathogenic effects.
Management
Treatment is supportive. Benzodiazepines are used to control agitation, anxiety, and autonomic symptoms such as tachycardia. Careful monitoring for complications such as hyperthermia and electrolyte disturbances is important.
Key Points
- Effects are unpredictable due to frequent adulteration.
- Hyponatremia and hyperthermia are important complications to monitor.
- Combining MDMA with other psychoactive substances increases risk of toxicity.
- Products marketed as “Molly” may not contain pure MDMA and can include other synthetic compounds.
- Published on
Toxicology – Nitrates and Nitrites
Source
Nitrates such as nitroglycerin and isosorbide dinitrate are commonly used in the treatment of coronary artery disease due to their vasodilatory effects. Nitrites, including amyl, butyl, and isobutyl nitrite, are often misused recreationally as inhalants and may be marketed under misleading labels such as “poppers,” cleaners, or deodorizers.
Typical Presentation
Individuals may present after inhaling these substances recreationally, often experiencing rapid onset of flushing, headache, and palpitations shortly after exposure.
Clinical Features
Common findings include headache, facial flushing, tachycardia, and hypotension due to vasodilation. In some cases, especially with nitrite exposure, methemoglobinemia may develop, leading to reduced oxygen delivery, cyanosis, and symptoms of hypoxia.
Mechanism of Action
Both nitrates and nitrites act as potent vasodilators, causing relaxation of vascular smooth muscle and resulting in decreased blood pressure with compensatory increase in heart rate. They can also oxidize hemoglobin to methemoglobin, impairing oxygen transport—this effect is more pronounced with nitrites.
Management
Treatment includes removal from exposure and supportive care. Intravenous fluids may be used for hypotension. In cases of methemoglobinemia, methylene blue (1–2 mg/kg IV) is the treatment of choice.
Key Points
Source
Nitrates such as nitroglycerin and isosorbide dinitrate are commonly used in the treatment of coronary artery disease due to their vasodilatory effects. Nitrites, including amyl, butyl, and isobutyl nitrite, are often misused recreationally as inhalants and may be marketed under misleading labels such as “poppers,” cleaners, or deodorizers.
Typical Presentation
Individuals may present after inhaling these substances recreationally, often experiencing rapid onset of flushing, headache, and palpitations shortly after exposure.
Clinical Features
Common findings include headache, facial flushing, tachycardia, and hypotension due to vasodilation. In some cases, especially with nitrite exposure, methemoglobinemia may develop, leading to reduced oxygen delivery, cyanosis, and symptoms of hypoxia.
Mechanism of Action
Both nitrates and nitrites act as potent vasodilators, causing relaxation of vascular smooth muscle and resulting in decreased blood pressure with compensatory increase in heart rate. They can also oxidize hemoglobin to methemoglobin, impairing oxygen transport—this effect is more pronounced with nitrites.
Management
Treatment includes removal from exposure and supportive care. Intravenous fluids may be used for hypotension. In cases of methemoglobinemia, methylene blue (1–2 mg/kg IV) is the treatment of choice.
Key Points
- Nitrites are more likely than nitrates to cause methemoglobinemia.
- These substances are sometimes misused for their short-lived vasodilatory and sensory effects
- Published on
Toxicology – Nitrous Oxide
Source
Nitrous oxide is a dissociative anesthetic available from medical gas supplies, automotive sources, and small canisters (“chargers”) used in whipped cream dispensers. It is often inhaled directly from these sources or via balloons at social events.
Typical Presentation
A college student presents with numbness and tingling in the hands and feet along with difficulty walking. On further questioning, he admits to frequent recreational use of nitrous oxide at parties, often inhaling it from balloons over several months.
Clinical Features
Acute effects include euphoria, analgesia, depersonalization, derealization, impaired coordination, reduced anxiety, and altered auditory perception. With chronic use, vitamin B12 deficiency may develop, leading to neurological symptoms such as paresthesia, ataxia, and hematologic abnormalities including megaloblastic anemia.
Mechanism of Action
Nitrous oxide acts as a weak dissociative anesthetic, likely through NMDA receptor antagonism and GABA receptor activation.
Management
Treatment involves discontinuation of exposure and supportive care. Vitamin B12 supplementation is indicated in patients with deficiency and neurological complications.
Key Points
Source
Nitrous oxide is a dissociative anesthetic available from medical gas supplies, automotive sources, and small canisters (“chargers”) used in whipped cream dispensers. It is often inhaled directly from these sources or via balloons at social events.
Typical Presentation
A college student presents with numbness and tingling in the hands and feet along with difficulty walking. On further questioning, he admits to frequent recreational use of nitrous oxide at parties, often inhaling it from balloons over several months.
Clinical Features
Acute effects include euphoria, analgesia, depersonalization, derealization, impaired coordination, reduced anxiety, and altered auditory perception. With chronic use, vitamin B12 deficiency may develop, leading to neurological symptoms such as paresthesia, ataxia, and hematologic abnormalities including megaloblastic anemia.
Mechanism of Action
Nitrous oxide acts as a weak dissociative anesthetic, likely through NMDA receptor antagonism and GABA receptor activation.
Management
Treatment involves discontinuation of exposure and supportive care. Vitamin B12 supplementation is indicated in patients with deficiency and neurological complications.
Key Points
- Recreational use often involves specialized devices (“crackers”) to release gas from small canisters.
- Nitrous oxide is widely accessible and commonly misused in social settings.
- Chronic exposure can lead to significant neurological and hematologic complications due to vitamin B12 depletion.
